TET2 c.3575G>T ;(p.G1192V)

Variant ID: 4-106164065-G-T

NM_001127208.2(TET2):c.3575G>T;(p.G1192V)

This variant was identified in 5 publications

View GRCh38 version.




Publications:


Outcomes and molecular profile of oligomonocytic CMML support its consideration as the first stage in the CMML continuum.

Blood Advances
Calvo, Xavier X; Roman-Bravo, David D; Garcia-Gisbert, Nieves N; Rodriguez-Sevilla, Juan Jose JJ; Garcia-Avila, Sara S; Florensa, Lourdes L; Gibert, Joan J; Fernández-Rodríguez, Concepción C; Salido, Marta M; Puiggros, Anna A; Espinet, Blanca B; Colomo, Luis L; Bellosillo, Beatriz B; Ferrer, Ana A; Arenillas, Leonor L
Publication Date: 2022-07-12

Variant appearance in text: TET2: 3575G>T; Gly1192Val
PubMed Link: 35709473
Variant Present in the following documents:
  • advancesADV2022007359-suppl1.pdf
View BVdb publication page



TET2 missense variants in human neoplasia. A proposal of structural and functional classification.

Molecular Genetics & Genomic Medicine
Bussaglia, Elena E; Antón, Rosa R; Nomdedéu, Josep F JF; Fuentes-Prior, Pablo P
Publication Date: 2019-07

Variant appearance in text: TET2: 3575G>T; Gly1192Val
PubMed Link: 31187595
Variant Present in the following documents:
View BVdb publication page



Targeted deep sequencing of CD34+ cells from peripheral blood can reproduce bone marrow molecular profile in myelodysplastic syndromes.

American Journal Of Hematology
Martin, Roman R; Acha, Pamela P; Ganster, Christina C; Palomo, Laura L; Dierks, Sascha S; Fuster-Tormo, Francisco F; Mallo, Mar M; Ademà, Vera V; Gómez-Marzo, Paula P; De Haro, Nuri N; Solanes, Neus N; Zamora, Lurdes L; Xicoy, Blanca B; Shirneshan, Katayoon K; Flach, Johanna J; Braulke, Friederike F; Schanz, Julie J; Kominowski, Arkadiusz A; Stromburg, Martin M; Brockmann, Alina A; Trümper, Lorenz L; Solé, Francesc F; Haase, Detlef D
Publication Date: 2018-06

Variant appearance in text: TET2: 3575G>T; G1192V
PubMed Link: 29575088
Variant Present in the following documents:
View BVdb publication page



TET2 Mutations Affect Non-CpG Island DNA Methylation at Enhancers and Transcription Factor-Binding Sites in Chronic Myelomonocytic Leukemia.

Cancer Research
Yamazaki, Jumpei J; Jelinek, Jaroslav J; Lu, Yue Y; Cesaroni, Matteo M; Madzo, Jozef J; Neumann, Frank F; He, Rong R; Taby, Rodolphe R; Vasanthakumar, Aparna A; Macrae, Trisha T; Ostler, Kelly R KR; Kantarjian, Hagop M HM; Liang, Shoudan S; Estecio, Marcos R MR; Godley, Lucy A LA; Issa, Jean-Pierre J JP
Publication Date: 2015-07-15

Variant appearance in text: TET2: G1192V
PubMed Link: 25972343
Variant Present in the following documents:
  • Main text
View BVdb publication page



Effects of TET2 mutations on DNA methylation in chronic myelomonocytic leukemia.

Epigenetics
Yamazaki, Jumpei J; Taby, Rodolphe R; Vasanthakumar, Aparna A; Macrae, Trisha T; Ostler, Kelly R KR; Shen, Lanlan L; Kantarjian, Hagop M HM; Estecio, Marcos R MR; Jelinek, Jaroslav J; Godley, Lucy A LA; Issa, Jean-Pierre J JP
Publication Date: 2012-02

Variant appearance in text: TET2: G1192V
PubMed Link: 22395470
Variant Present in the following documents:
  • Main text
View BVdb publication page